AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis

• Xiaoliang Chen ,

  Contributed equally to this work with: Xiaoliang Chen, Jinbo Lin

  Affiliation Shenzhen Guangming district center for disease control and prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Jinbo Lin ,

  Contributed equally to this work with: Xiaoliang Chen, Jinbo Lin

  Affiliation Longgang district central hospital of Shenzhen, Shenzhen, Guangdong, P.R. China

  ⨯
• Yi Liu,

  Affiliation Shenzhen Guangming district center for disease control and prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Ji Peng,

  Affiliation Shenzhen Center for Chronic Disease Prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Yong Cao,

  Affiliation Shenzhen Guangming district center for disease control and prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Zhan Su,

  Affiliation Shenzhen Guangming district center for disease control and prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Tieqiang Wang,

  Affiliation Shenzhen Guangming district center for disease control and prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Jinquan Cheng ,

  * E-mail: cjinquan@szcdc.net (JC); hud@szu.edu.cn (DH)

  Affiliation Department of Molecular Biology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, P.R. China

  ⨯
• Dongsheng Hu

  * E-mail: cjinquan@szcdc.net (JC); hud@szu.edu.cn (DH)

  Affiliation School of Medicine, Shenzhen University, Shenzhen, Guangdong, P.R. China

  ⨯